Article 17 Mar 2026 Provisional Text Of The Political Agreement On The Reform To The EU Regulatory Framework For Medicinal Products Is Published United Kingdom Healthcare
Article 24 Feb 2026 MHRA Launches Targeted Consultation On Indefinite Recognition Of CE‑Marked Medical Devices United States Healthcare
Article 18 Feb 2026 UK Government Sets Out 2026 Branded Medicines Statutory Scheme Repayment Rate United Kingdom Healthcare
Article 05 Dec 2025 US-UK Pharmaceutical Pricing Deal: UK Agrees Increase In Amounts It Can Pay For Innovative Medicines And Reduction Of Rebate Rates United States Healthcare
Article 14 Nov 2025 Rewriting The Rulebook: MHRA's Vision For Rare Disease Therapies United States Healthcare
Article 09 Sep 2025 UK Government And Pharmaceutical Industry Fail To Reach Agreement On Amendments To Medicines Pricing Scheme United Kingdom Healthcare
Article 03 Apr 2025 ABPI Calls For Changes To "Unsustainable" Medicines Pricing Scheme United Kingdom Healthcare
Article 09 Oct 2024 A New 2024 Code For The British Pharmaceutical Industry – "The Future Is Orange" United States Healthcare
Article 14 Aug 2024 Pharmaceutical Advertising Laws And Regulations England & Wales 2024 European Union Healthcare
Article 16 Jul 2024 What Does The New UK Government Mean For Life Sciences? United Kingdom Healthcare
Article 12 Jul 2023 BGMA Refused Permission For Judicial Review In Relation To Negotiation Of The Voluntary Scheme United Kingdom Healthcare
Article 13 Jun 2023 Product Liability Laws And Regulations An Update On Proposed Changes To The Product Liability Directive 2023 European Union Consumer
Article 09 Feb 2023 UK PMCPA Publishes Long-awaited Guidance On Use Of Social Media United Kingdom Media & IT
Article 15 Jul 2021 Pharmaceutical Advertising 2021: England & Wales Chapter European Union Media & IT
Article 27 Jan 2021 New 2021 Code Of Practice For The British Pharmaceutical Industry United States Healthcare